Vistagen Therapeutics Inc (VTGN)
2.54
-0.07
(-2.68%)
USD |
NASDAQ |
Nov 21, 15:23
Vistagen Therapeutics Price to Book Value: 0.7606 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 0.7816 |
| November 19, 2024 | 0.7996 |
| November 18, 2024 | 0.7936 |
| November 15, 2024 | 0.7876 |
| November 14, 2024 | 0.8176 |
| November 13, 2024 | 0.8445 |
| November 12, 2024 | 0.8775 |
| November 11, 2024 | 0.9044 |
| November 08, 2024 | 0.9404 |
| November 07, 2024 | 0.9344 |
| November 06, 2024 | 0.9284 |
| November 05, 2024 | 0.9166 |
| November 04, 2024 | 0.937 |
| November 01, 2024 | 0.905 |
| October 31, 2024 | 0.8963 |
| October 30, 2024 | 0.8992 |
| October 29, 2024 | 0.8875 |
| October 28, 2024 | 0.8817 |
| October 25, 2024 | 0.8759 |
| October 24, 2024 | 0.8817 |
| October 23, 2024 | 0.8817 |
| October 22, 2024 | 0.9021 |
| October 21, 2024 | 0.873 |
| October 18, 2024 | 0.8934 |
| October 17, 2024 | 0.8904 |
| Date | Value |
|---|---|
| October 16, 2024 | 0.8788 |
| October 15, 2024 | 0.8497 |
| October 14, 2024 | 0.8788 |
| October 11, 2024 | 0.8817 |
| October 10, 2024 | 0.8788 |
| October 09, 2024 | 0.8497 |
| October 08, 2024 | 0.8555 |
| October 07, 2024 | 0.8352 |
| October 04, 2024 | 0.8759 |
| October 03, 2024 | 0.8584 |
| October 02, 2024 | 0.873 |
| October 01, 2024 | 0.8904 |
| September 30, 2024 | 0.8759 |
| September 27, 2024 | 0.7925 |
| September 26, 2024 | 0.7745 |
| September 25, 2024 | 0.7899 |
| September 24, 2024 | 0.777 |
| September 23, 2024 | 0.7822 |
| September 20, 2024 | 0.8132 |
| September 19, 2024 | 0.7745 |
| September 18, 2024 | 0.7732 |
| September 17, 2024 | 0.8003 |
| September 16, 2024 | 0.8132 |
| September 13, 2024 | 0.8493 |
| September 12, 2024 | 0.8235 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6358
Minimum
Dec 28 2022
57.55
Maximum
Dec 30 2020
3.804
Average
2.678
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.237 |
| Theriva Biologics Inc | 0.1400 |
| Oragenics Inc | 2.221 |
Price to Book Value Related Metrics
| PS Ratio | 85.31 |
| Price | 2.54 |
| Earnings Yield | -52.85% |
| Market Cap | 70.72M |